TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 50 filers reported holding TALARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,092,759 | -2.0% | 1,100,626 | +6.0% | 0.00% | – |
| Q2 2023 | $3,155,128 | +49.2% | 1,037,871 | -7.7% | 0.00% | – |
| Q1 2023 | $2,114,900 | +97.1% | 1,124,947 | +7.0% | 0.00% | – |
| Q4 2022 | $1,072,848 | -59.9% | 1,051,811 | +3.4% | 0.00% | – |
| Q3 2022 | $2,675,000 | -41.7% | 1,016,998 | -0.1% | 0.00% | – |
| Q2 2022 | $4,591,000 | -54.7% | 1,018,125 | -1.2% | 0.00% | – |
| Q1 2022 | $10,142,000 | -35.7% | 1,030,742 | -0.0% | 0.00% | – |
| Q4 2021 | $15,761,000 | +194.9% | 1,030,822 | +161.5% | 0.00% | – |
| Q3 2021 | $5,345,000 | -6.9% | 394,178 | +0.9% | 0.00% | – |
| Q2 2021 | $5,741,000 | – | 390,826 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $7,713,000 | 11.20% |
| Aisling Capital Management LP | 175,000 | $460,000 | 0.30% |
| Artal Group S.A. | 2,064,262 | $5,429,000 | 0.23% |
| Cormorant Asset Management, LP | 900,649 | $2,369,000 | 0.17% |
| Eventide Asset Management | 1,561,092 | $4,106,000 | 0.08% |
| Blackstone Inc. | 8,089,315 | $21,275 | 0.08% |
| Logos Global Management LP | 197,913 | $521,000 | 0.06% |
| Values First Advisors, Inc. | 30,715 | $81,000 | 0.06% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $8,652,000 | 0.04% |
| CAAS CAPITAL MANAGEMENT LP | 297,707 | $783,000 | 0.04% |